HansBiomed Corp. is a leading player in tissue engineering, plastic surgery, and medical devices in Korea. Founded in 1999, the company has established itself as a global leader in the biotechnology industry. HansBiomed Corp. offers a diverse range of products in the fields of human tissue and medical devices.
Their biologics line includes Allograft Bone products that promote bone regeneration and Allograft Skin products that provide healing effects for various medical applications. In the medical devices segment, notable offerings include BELLAGEL®, MINT LIFT®, EZ-Tcon™, and Lion, catering to different surgical and cosmetic needs.
Moreover, the company also ventures into cosmeceutical products, providing high-end Stem Cell-based treatments through their Dia-Solution line, along with skin and home care products.
Although there is no available information on the company's current headquarters or its last investment and investors, HansBiomed Corp. stands out as a prominent entity in the healthcare and medical devices sectors, presenting noteworthy opportunities for potential investors seeking to explore the biotechnology landscape.
There is no investment information
No recent news or press coverage available for HansBiomed Corp..